Page last updated: 2024-08-21

fluorobenzenes and Hyperlipoproteinemia Type I

fluorobenzenes has been researched along with Hyperlipoproteinemia Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lupattelli, G; Mannarino, E; Roscini, AR; Siepi, D	1

Other Studies

1 other study(ies) available for fluorobenzenes and Hyperlipoproteinemia Type I

Article	Year
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report. Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:5 Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type I; Male; Middle Aged; Myocardial Infarction; Niacin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2010

Article

Year

Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.

Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:5

Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type I; Male; Middle Aged; Myocardial Infarction; Niacin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides

2010